Multiple Myeloma (risk factor)

Recommendations for COVID Vaccination

We recommend that patients with myeloma and related disorders, whether on or off chemotherapy, receive COVID vaccination as soon as it is available and offered to…

Subscribe to

RNAi Explained

Dr. Bersell explores RNA interference (RNAi) technology and its applications in treating ATTR-CM and ATTR-PN. Learn about mechanism of action, clinical evidence, and patient outcomes.

Learn More

Expert Perspectives on Attruby®

Dr. Barry Trachtenberg and ATTR community members discuss Attruby™ (acoramidis), covering clinical data, patient perspectives, and treatment considerations.

Watch Discussion